Browse 26479 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| January 7th, 2026 |
Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low- and Middle-Income Countries and US Tribal Populations (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2026 |
Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low- and Middle-Income Countries and US Tribal Populations (R61/R33 Clinical Trial Required) |
National Institutes of Health |
| June 20th, 2025 |
The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| September 7th, 2025 |
Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| May 30th, 2025 |
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| December 6th, 2024 |
Strengthening Malaria Control for High-Risk Communities |
Thailand USAID-Bangkok |
| January 6th, 2028 |
NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
| February 27th, 2025 |
Human Virome Program: Developing novel and innovative tools to interrogate and annotate the human virome (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 28th, 2025 |
Centers for Accelerating Phage (Bacteriophage) Therapy to Combat ESKAPE Pathogens (CAPT-CEP) (P01 Clinical Trial Not Allowed) |
National Institutes of Health |
| December 26th, 2024 |
Pilot projects to enhance utility and usage of data sets from the Molecular Transducers of Physical Activity Consortium (MoTrPAC) (R03 Clinical Trials Not allowed) |
National Institutes of Health |
| June 15th, 2027 |
BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional) |
National Institutes of Health |
| October 20th, 2027 |
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 20th, 2027 |
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 20th, 2027 |
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
| December 5th, 2024 |
Environmental Health Disparities Centers (P50) Clinical Trial Optional |
National Institutes of Health |
| December 20th, 2024 |
Strengthening Systems for Health Security Activity (SSHS) |
Peru USAID-Lima |
| October 15th, 2027 |
NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional) |
National Institutes of Health |
| January 10th, 2025 |
TMD Collaborative for IMproving PAtient-Centered Translational Research (TMD IMPACT) (U54 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2026 |
NCI Small Grants Program for Cancer Research (NCI Omnibus) (R03 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2026 |
Co-infection and Cancer (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
|
| December 17th, 2024 |
BURMA: Resilient Tuberculosis Response in Myanmar (RTBR) Activity |
Burma USAID - Rangoon |
| November 15th, 2024 |
USAID Maisha Bora Activity |
Democratic Republic of the Congo USAID-Kinshasa |
| November 16th, 2025 |
Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R21 - Clinical Trial Optional) |
National Institutes of Health |
| November 5th, 2025 |
Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R01 - Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2027 |
Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required) |
National Institutes of Health |
| October 25th, 2024 |
Mental Health and Psychosocial Support (MHPSS) Program in Ethiopia |
Ethiopia USAID-Addis Ababa |
| July 14th, 2026 |
Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required) |
National Institutes of Health |
| December 3rd, 2026 |
Emerging Global Leader Award (K43 Independent Clinical Trial Required) |
National Institutes of Health |
| December 3rd, 2026 |
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
| September 30th, 2025 |
Building Biomedical Engineering Education, Research, and Innovation at Historically Black Colleges and Universities (HBCU eBETA) (UG3/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 19th, 2025 |
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial required) |
National Institutes of Health |
| October 14th, 2026 |
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 14th, 2026 |
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) |
National Institutes of Health |
| March 19th, 2025 |
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional) |
National Institutes of Health |
| January 31st, 2025 |
New Therapeutic Strategies for Genital Herpes (R21/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
| February 14th, 2025 |
Human Brain Single-cell Genomics Explorer (U24 - Clinical Trial Not Allowed) |
National Institutes of Health |
| January 6th, 2028 |
Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required) |
National Institutes of Health |
| January 7th, 2027 |
Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) |
National Institutes of Health |
| May 7th, 2025 |
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| May 7th, 2025 |
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
